Key takeaways
Orencia (abatacept) and Remicade (infliximab) are used to treat autoimmune conditions, but they have some key differences. Orencia is available as an injection under the skin or an IV infusion, while Remicade is only given as an IV infusion by a healthcare provider. Orencia is used for rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and preventing graft-versus-host disease. On the other hand, Remicade treats a broader range of conditions, including Crohn's disease, ulcerative colitis, ankylosing spondylitis, and severe plaque psoriasis. Orencia can be used in children as young as 2 years old for certain conditions, while Remicade is approved for children 6 years and older for ulcerative colitis and Crohn's disease. Remicade has a higher risk of serious side effects, including infections, cancer, and heart problems, compared to Orencia. Additionally, Orencia can be self-administered at home, but Remicade requires administration in a clinical setting.
